An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...
With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...
Morning Overview on MSN
Common gene variant may raise Alzheimer’s risk; researchers eye gene therapy
A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...
UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T ...
UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...
Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...
For patients with rare and devastating neurological disorders, treatment options can seem few and far between. However, gene therapy research, led by Dr. Russell Lonser and Dr. Brad Elder, is hoping ...
From an early age, Allison Keeler ’05 (biotechnology) always knew she wanted to be a scientist. As an adult, that dream has come true as she is an assistant professor in the Department of Pediatrics ...
Why Theator, SamaCare, Children's Health of Philadelphia, and Merck are among the 20 most innovative healthcare companies in ...
The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.
Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the journal Human Gene Therapy. To improve the efficacy of gene therapy when using anti-sickling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results